Back to search

Article

Effects of Specialized Pro-Resolving Mediators and Telerehabilitation on Fatigue, Dyspnea, and Quality of Life in Post‑COVID‑19 Condition: The ARACOV-02 Randomized Controlled Trial.

2026-06-10

Abstract excerpt

<title>Abstract</title> <p> <bold>Background:</bold> Post‑COVID‑19 Condition (PCC) is characterized by persistent multisystem symptoms, with fatigue and dyspnea among the most disabling. Specialized pro‑resolving mediators (SPMs) may modulate chronic inflammation, while telerehabilitation has emerged as an accessible therapeutic strategy. This randomized controlled trial (ARACOV‑02) evaluated the combined effec...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
988eaab3-5648-500c-bfc8-95ff4d307de9
DOI
10.21203/rs.3.rs-9354365/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Effects of Specialized Pro-Resolving Mediators and Telerehabilitation on Fatigue, Dyspnea, and Quality of Life in Post‑COVID‑19 Condition: The ARACOV-02 Randomized Controlled Trial.DOI 10.21203/rs.3.rs-9354365/v1
Select a neighboring publication to make it the new centre.